{"id":"https://openalex.org/W7223039367","doi":"https://doi.org/10.3389/fimmu.2026.1959178","title":"Development and validation of the IFN-\u03b3 FlowCytoScreen for cytokine-based potency assessment of advanced therapy medicinal products","display_name":"Development and validation of the IFN-\u03b3 FlowCytoScreen for cytokine-based potency assessment of advanced therapy medicinal products","publication_year":2026,"publication_date":"2026-10-20","ids":{"openalex":"https://openalex.org/W7223039367","doi":"https://doi.org/10.3389/fimmu.2026.1959178","pmid":"https://pubmed.ncbi.nlm.nih.gov/42978955","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13727744"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1959178","doi":"https://doi.org/10.3389/fimmu.2026.1959178","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1959178","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1959178/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1959178/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045079490","display_name":"Silvia Carloni","orcid":"https://orcid.org/0000-0003-3634-3454","observed_orcids":["https://orcid.org/0000-0003-3634-3454"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvia Carloni","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067537551","display_name":"Claudia Piccinini","orcid":"https://orcid.org/0000-0001-5862-6207","observed_orcids":["https://orcid.org/0000-0001-5862-6207"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Claudia Piccinini","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061756597","display_name":"Chiara Arienti","orcid":"https://orcid.org/0000-0002-2265-828X","observed_orcids":["https://orcid.org/0000-0002-2265-828X"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Arienti","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019251075","display_name":"Dario Armando Leone","orcid":"https://orcid.org/0000-0002-4103-670X","observed_orcids":["https://orcid.org/0000-0002-4103-670X"]},"institutions":[{"id":"https://openalex.org/I137469784","display_name":"Miltenyi Biotec (Germany)","ror":"https://ror.org/00qhe6a56","country_code":"DE","type":"company","lineage":["https://openalex.org/I137469784"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dario Armando Leone","raw_affiliation_strings":["Miltenyi Biotec s.r.l"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Miltenyi Biotec s.r.l","institution_ids":["https://openalex.org/I137469784"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043380987","display_name":"Elena Pancisi","orcid":"https://orcid.org/0000-0002-8780-2342","observed_orcids":["https://orcid.org/0000-0002-8780-2342"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Pancisi","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027551885","display_name":"Francesca Fanini","orcid":"https://orcid.org/0000-0002-3903-9514","observed_orcids":["https://orcid.org/0000-0002-3903-9514"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Fanini","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075521862","display_name":"Sara Pignatta","orcid":"https://orcid.org/0000-0001-5464-0052","observed_orcids":["https://orcid.org/0000-0001-5464-0052"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sara Pignatta","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082722926","display_name":"Valentina Soldati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valentina Soldati","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058171569","display_name":"Monica Stefanelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Monica Stefanelli","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081856992","display_name":"Anna Maria Granato","orcid":"https://orcid.org/0000-0002-8609-4217","observed_orcids":["https://orcid.org/0000-0002-8609-4217"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Maria Granato","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080003827","display_name":"Flavia Foca","orcid":"https://orcid.org/0000-0002-5529-4769","observed_orcids":["https://orcid.org/0000-0002-5529-4769"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Flavia Foca","raw_affiliation_strings":["Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014371052","display_name":"Jenny Bulgarelli","orcid":"https://orcid.org/0000-0002-6551-0189","observed_orcids":["https://orcid.org/0000-0002-6551-0189"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Jenny Bulgarelli","raw_affiliation_strings":["Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055462054","display_name":"Laura Ridolfi","orcid":"https://orcid.org/0000-0003-1870-3380","observed_orcids":["https://orcid.org/0000-0003-1870-3380"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Ridolfi","raw_affiliation_strings":["Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071634163","display_name":"Massimiliano Petrini","orcid":"https://orcid.org/0000-0002-8942-0890","observed_orcids":["https://orcid.org/0000-0002-8942-0890"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimiliano Petrini","raw_affiliation_strings":["Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immuno-Gene Therapy Factory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","institution_ids":["https://openalex.org/I4210097834"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5067537551"],"corresponding_institution_ids":["https://openalex.org/I4210097834"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.73103215,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1959178","last_page":"1959178"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.024700000882148743,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-therapy-medicinal-products","display_name":"advanced therapy medicinal products","score":0.9589999914169312},{"id":"https://openalex.org/keywords/dendritic-cell-vaccine","display_name":"dendritic cell vaccine","score":0.925000011920929},{"id":"https://openalex.org/keywords/assay-validation","display_name":"assay validation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.6639999747276306},{"id":"https://openalex.org/keywords/quality-control","display_name":"quality control","score":0.5740000009536743}],"concepts":[{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.7146999835968018},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.6725999712944031},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4912000000476837},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.486299991607666},{"id":"https://openalex.org/C63479239","wikidata":"https://www.wikidata.org/wiki/Q7353546","display_name":"Robustness (evolution)","level":3,"score":0.4074999988079071},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3662000000476837},{"id":"https://openalex.org/C2780449318","wikidata":"https://www.wikidata.org/wiki/Q18344773","display_name":"Critical quality attributes","level":3,"score":0.3474999964237213},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3292999863624573},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.328000009059906},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3203999996185303},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.31700000166893005},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.296099990606308},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.296099990606308},{"id":"https://openalex.org/C48044578","wikidata":"https://www.wikidata.org/wiki/Q727490","display_name":"Scalability","level":2,"score":0.2782000005245209},{"id":"https://openalex.org/C2985179714","wikidata":"https://www.wikidata.org/wiki/Q627335","display_name":"Work flow","level":2,"score":0.260699987411499},{"id":"https://openalex.org/C200601418","wikidata":"https://www.wikidata.org/wiki/Q2193887","display_name":"Reliability engineering","level":1,"score":0.25270000100135803}],"mesh":[{"descriptor_ui":"D003713","descriptor_name":"Dendritic Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D003713","descriptor_name":"Dendritic Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058501","descriptor_name":"Enzyme-Linked Immunospot Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1959178","doi":"https://doi.org/10.3389/fimmu.2026.1959178","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1959178","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1959178/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13727744","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13727744/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13727744/pdf/fimmu-17-1959178.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42978955","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42978955","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:bf58ec74f644437d8aa7773ff04c621a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/bf58ec74f644437d8aa7773ff04c621a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1959178","doi":"https://doi.org/10.3389/fimmu.2026.1959178","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1959178","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1959178/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321781","display_name":"Ministero della Salute","ror":"https://ror.org/00789fa95"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223039367.pdf","grobid_xml":"https://content.openalex.org/works/W7223039367.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W129996036","https://openalex.org/W1987375408","https://openalex.org/W2102403364","https://openalex.org/W2327037637","https://openalex.org/W2586195606","https://openalex.org/W2620874488","https://openalex.org/W2806979602","https://openalex.org/W3028510355","https://openalex.org/W3138477144","https://openalex.org/W3165021257","https://openalex.org/W4210863439","https://openalex.org/W4223539173","https://openalex.org/W4283381828","https://openalex.org/W4283819837","https://openalex.org/W4377564583","https://openalex.org/W4378806273","https://openalex.org/W4380083274","https://openalex.org/W4383954765","https://openalex.org/W4384695221","https://openalex.org/W4389118834","https://openalex.org/W4391233139","https://openalex.org/W4392955936","https://openalex.org/W4400412089","https://openalex.org/W4404868753","https://openalex.org/W4407010821","https://openalex.org/W4409642785"],"related_works":["https://openalex.org/W2083676589","https://openalex.org/W4389118834","https://openalex.org/W2411863274","https://openalex.org/W2055561436","https://openalex.org/W4409784142","https://openalex.org/W2622992526","https://openalex.org/W2399373195","https://openalex.org/W1998793553","https://openalex.org/W7134914605","https://openalex.org/W1540900118"],"abstract_inverted_index":{"Introduction:":[0],"Robust":[1],"quality":[2,227],"control":[3,228],"methods":[4],"are":[5],"required":[6],"to":[7,59,93,126,147,151,209],"ensure":[8,102],"the":[9,33,69,95,120,130,158,167],"safety,":[10],"efficacy":[11],"and":[12,50,61,115,141,163,177,195,204,216,229,256],"consistency":[13],"of":[14,48,71,97,143,182,250],"advanced":[15,225],"therapy":[16,226],"medicinal":[17],"products.":[18],"Potency":[19],"assays":[20],"play":[21],"a":[22,46,63,149,192,221],"critical":[23],"role":[24],"in":[25,137,213,232,253],"evaluating":[26],"their":[27],"biological":[28],"activity.":[29],"While":[30],"ELISpot":[31,121,173],"remains":[32],"reference":[34],"method":[35,208],"for":[36,53,68,110,200,224],"single-cell":[37,72],"cytokine":[38,144,201],"analysis,":[39],"it":[40,220],"has":[41],"several":[42],"limitations":[43],"such":[44],"as":[45],"lack":[47],"standardisation":[49],"limited":[51],"capacity":[52],"multiparametric":[54,244],"characterisation.":[55],"This":[56],"study":[57],"aimed":[58],"develop":[60],"validate":[62],"flow":[64,89,197,236],"cytometry-based":[65,198],"potency":[66,96],"assay":[67,106,122,190],"assessment":[70],"IFN-\u03b3":[73,81],"secretion.":[74],"Methods:":[75],"The":[76,188,235],"commercially":[77],"available":[78],"Miltenyi":[79],"Biotec":[80],"Secretion":[82],"Assay":[83],"-":[84],"Detection":[85],"Kit,":[86],"based":[87],"on":[88],"cytometry,":[90],"was":[91,107,123],"modified":[92],"assess":[94,127],"dendritic":[98],"cell-based":[99],"vaccines.":[100],"To":[101],"its":[103,240],"reliability,":[104],"our":[105],"rigorously":[108],"evaluated":[109],"specificity,":[111,159],"linearity,":[112,160],"accuracy,":[113,161],"robustness":[114,162],"precision.":[116],"Comparative":[117,170],"analysis":[118,171,203],"with":[119,172,179],"also":[124],"performed":[125],"agreement":[128],"between":[129],"two":[131],"methods.":[132],"Results:":[133],"Method":[134],"development":[135],"resulted":[136],"reduced":[138],"sample":[139],"requirements":[140],"optimisation":[142],"secretion":[145,202],"conditions":[146],"generate":[148],"response":[150],"antigen-presenting":[152],"cell":[153],"stimulus.":[154],"Validation":[155],"showed":[156],"that":[157],"precision":[164],"consistently":[165],"met":[166],"acceptance":[168],"criteria.":[169],"demonstrated":[174],"high":[175],"correlation":[176],"agreement,":[178],"no":[180],"evidence":[181],"systematic":[183],"or":[184],"proportional":[185],"error.":[186],"Discussion:":[187],"developed":[189],"provides":[191],"reliable,":[193],"scalable":[194],"efficient":[196],"approach":[199],"represents":[205],"an":[206],"alternative":[207],"ELISpot.":[210],"Its":[211],"advantages":[212],"sensitivity,":[214],"efficiency":[215],"cost":[217],"effectiveness":[218],"make":[219],"valuable":[222],"tool":[223],"immune":[230,245],"monitoring":[231],"clinical":[233,257],"research.":[234],"cytometry":[237],"further":[238],"enhances":[239],"potential":[241],"by":[242],"enabling":[243],"profiling,":[246],"supporting":[247],"comprehensive":[248],"characterisation":[249],"cellular":[251],"products":[252],"both":[254],"preclinical":[255],"applications.":[258]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-10-21T00:00:00"}